Christopher M. Yea
2020
In 2020, Christopher M. Yea earned a total compensation of $926K as Chief Development Officer at Carbylan Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Option Awards | $480,773 |
|---|---|
| Salary | $420,000 |
| Other | $25,271 |
| Total | $926,044 |
Yea received $480.8K in option awards, accounting for 52% of the total pay in 2020.
Yea also received $420K in salary and $25.3K in other compensation.
Rankings
In 2020, Christopher M. Yea's compensation ranked 8,938th out of 13,090 executives tracked by ExecPay. In other words, Yea earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,938 out of 13,090 | 32nd |
Division Manufacturing | 3,819 out of 5,620 | 32nd |
Major group Chemicals And Allied Products | 1,547 out of 2,253 | 31st |
Industry group Drugs | 1,350 out of 1,953 | 31st |
Industry Pharmaceutical Preparations | 1,000 out of 1,458 | 31st |
Source: SEC filing on August 25, 2020.
Yea's colleagues
We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2020.